hubert_hackl Profile Banner
Hubert Hackl Profile
Hubert Hackl

@hubert_hackl

Followers
54
Following
26
Media
0
Statuses
26

Group Leader in Computational Biology and Immuno-Oncology

Innsbruck, Austria
Joined January 2020
Don't wanna be here? Send us removal request.
@LabWaggoner
Waggoner Lab
1 year
Epigenetic reactivation of transposable elements induces tumor-enriched antigens in glioblastoma but also some in proliferating nontumor cells @NatureGenet @twang5 @AlbertHKimMDPhD @Nakul2234 @leung_holden https://t.co/FI92Wvg6vO
1
45
169
@tangming2005
Ming "Tommy" Tang
1 year
130 tumors from 94 patients! Mapping spatial organization and genetic cell-state regulators to target immune evasion in ovarian cancer
nature.com
Nature Immunology - Here the authors provide a resource for ovarian cancer combining spatial transcriptomics, genomics, CRISPR Perturb-seq screens and in silico methods to focus on T cells and...
1
20
114
@EhxGregory
Gregory Ehx
2 years
Excited to share that our BamQuery (BQ) article has been published in @GenomeBiology! Congrats @MariaVPetite from @IRIC_umontreal for the amazing job 👏! ➡️ https://t.co/T1VXyuUiRT BQ helps prioritize #tumor antigens & design #cancer #vaccines. How is it useful? A thread🧵:
1
1
2
@Schumacher_lab
Ton Schumacher Lab
3 years
Excited to share STAPLER, a language model to predict TCR – pMHC reactivity that outperforms prior models. And for ML aficionados: Description of a new data leakage problem inherent to a common negative data generation strategy. https://t.co/dsLeYJoT7v 🧵👇
Tweet card summary image
biorxiv.org
The prediction of peptide-MHC (pMHC) recognition by αβ T-cell receptors (TCRs) remains a major biomedical challenge. Here, we develop STAPLER (Shared TCR And Peptide Language bidirectional Encoder...
2
37
110
@mfgrp
Michael Fischbach
3 years
Today we report that an engineered skin bacterium, swabbed gently on the head of a mouse, can unleash a potent immune response against a distant tumor. @yerinchen led the charge w/ help from @DjenetBousbaine, @VeinbachsA, @BelkaidLab. @ScienceMagazine 1/26 https://t.co/bgW3C7CJgh
Tweet card summary image
science.org
A system to express tumor antigens in the skin commensal bacterium Staphylococcus epidermidis elicits T cells that treat local and systemic tumors.
39
422
1K
@obenaufa
Anna Obenauf
3 years
42: the answer to everything? We are so excited to share our study led by the fantastic @leiendeckerlu & @fh_fingolfin, which identified HPV42 as an oncogenic #virus that causes skin #cancer & a germ cell-like program conserved in all HPV+ cancers. 🧵👇/1 https://t.co/Vu6PbqBWDk
34
54
267
@Nature
nature
3 years
Nature research paper: Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
1
11
39
@NaturePortfolio
Nature Portfolio
5 years
A HLA peptidomic analysis in Nature identifies recurrent intracellular bacteria-derived peptides presented on HLA-I and HLA-II molecules in melanoma tumours, revealing how bacteria can modulate immune functions and responses to cancer therapies. https://t.co/axQs7levJe
0
18
67
@GfellerD
David Gfeller
5 years
Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting: Cell Reports Medicine
6
33
89
@CD_AACR
Cancer Discovery
5 years
Just published #OnlineFirst: An empirical antigen selection method identifies #neoantigens that either elicit broad anti-tumor T cell responses or drive tumor growth. @jessaflecht @GenoceaBio https://t.co/Yjr1wy8ILx
0
1
2
@CellCellPress
Cell
5 years
New Article now online: Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
1
31
68
@EytanRuppin
Eytan Ruppin, MD, PhD
5 years
The Ruppin lab ( https://t.co/xuZSOAmniU) has a few postdoc openings summer 2021. We study cancer genomics, metabolism and immunotherapy, collaborating with experimental and clinical labs in the NCI and beyond to develop new precision oncology treatment approaches. Pls RT! :)
Tweet card summary image
ccr.cancer.gov
My research is focused on multi-disciplinary algorithmic computationally driven analysis of large-scale biomedical omics and clinical data, with an emphasis on AI and machine / deep learning approa...
1
33
65
@TELL_Starlinger
Patrick Starlinger_TELL International
5 years
Remember the last patient you lost due to postoperative liver failure? We created an App (Type: TELLAPRIABLI) together with 37binary based on data of >12000pts that allows preoperative risk assessment of postoperative MORTALITY! @Seanpcleary @hubert_hackl @j_starlinger @hpb_so
4
18
49
@samuels_yardena
yardena samuels
5 years
Anti-tumour immunity induces aberrant peptide presentation in melanoma | Nature. Our paper just published in Nature -A wonderful collaboration with Reuven Agami, Johanna Olweus, Daniel Peeper, Stern Ginossar Tamar Geiger. Congratulation to the whole team!
29
54
235
@fcicca
Francesca Ciccarelli
5 years
Happy to share our map of #CRC response to immunotherapy incl. #KEYNOTE177 samples. Huge effort by @RedaKeddar @AmeAchaSag Michele, Lucia (not on Twitter) @JoSpencerLab clinical colleagues @uclcancer fabulous STPs @TheCrick and many more. Summary 👇 1/8
Tweet card summary image
biorxiv.org
To dissect the determinants of the heterogeneous response of colorectal cancer (CRC) to immune checkpoint blockade, we profile tumour and immune infiltrates of 721 cancer regions from 29 patients...
2
12
25
@EytanRuppin
Eytan Ruppin, MD, PhD
5 years
A systematic study of predictors of irAE risk in anti-PD1/PDL1 treatment across 26 tumor types. Tweetorial summary 1/n
nature.com
Nature Communications - Immunotherapy, the reactivation of the immune system to recognize cancer cells, can be accompanied by severe adverse effects. Here, the authors use pharmacovigilance and...
1
16
49
@IdoAmitLab
IdoAmitLab
6 years
Differentiation of transplanted haematopoietic stem cells tracked by single-cell transcriptomic analysis | Nature Cell Biology
0
19
46
@Francesca_Fin_
Francesca Finotello
6 years
#Scirpy: A Scanpy extension for analyzing #singlecell #TCR sequencing data in #python https://t.co/Hd2wvGIibP @grsturm @imed_tweets
2
14
25